26
|
Kong X, Chen H, Wu P, Ma R, Pan F. Impact of R&D innovation and political background on corporate growth: A study based on private listed companies in China. PLoS One 2024; 19:e0297329. [PMID: 38723045 PMCID: PMC11081349 DOI: 10.1371/journal.pone.0297329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Accepted: 12/22/2023] [Indexed: 05/13/2024] Open
Abstract
Based on a review of related concepts and theories this study investigates the different impacts of research and development (R&D) innovation and political background on corporate growth in a particular context. Unlike other studies, we integrate these two factors. We empirically analyze 6079 sets of data from 1292 A-share private manufacturing enterprises in Shanghai and Shenzhen from 2012 to 2019. The results show that these factors directly impact corporate growth and have heterogeneous effects at different enterprise growth levels. We find the effect of R&D innovation on corporate growth is more pronounced for young firms. These findings highlight the need for firms to adjust their investments in R&D innovation and political backgrounds at different stages of development to adapt to different markets and political environments.
Collapse
|
27
|
Ide K. Japan can embrace open science - but flexible approaches are key. Nature 2024; 629:286. [PMID: 38714814 DOI: 10.1038/d41586-024-01340-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2024]
|
28
|
Morimoto J. Expat grants won't fix Brazilian research. Nature 2024; 629:261. [PMID: 38714815 DOI: 10.1038/d41586-024-01324-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2024]
|
29
|
De Ambrosio M, Koop F. Argentina's pioneering nuclear research threatened by huge budget cuts. Nature 2024; 629:512-513. [PMID: 38714904 DOI: 10.1038/d41586-024-01283-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/15/2024]
|
30
|
The EU's ominous emphasis on 'open strategic autonomy' in research. Nature 2024; 628:8. [PMID: 38570717 DOI: 10.1038/d41586-024-00962-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2024]
|
31
|
Lenharo M. AI consciousness: scientists say we urgently need answers. Nature 2024; 625:226. [PMID: 38129616 DOI: 10.1038/d41586-023-04047-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2023]
|
32
|
Westmore M, Bowdery M, Cody A, Dunham K, Goble D, van der Linden B, Whitlock E, Williams E, Lujan Barroso C. How an international research funder's forum developed guiding principles to ensure value and reduce waste in research. F1000Res 2023; 12:310. [PMID: 38845618 PMCID: PMC11153987 DOI: 10.12688/f1000research.128797.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/06/2024] [Indexed: 06/09/2024] Open
Abstract
Background: When health-related research funding agencies choose to fund research, they balance a number of competing issues: costs, stakeholder views and potential benefits. The REWARD Alliance, and the related Lancet-REWARD Campaign, question whether those decisions are yielding all the value they could. Methods: A group of health-related research funding agencies, organisations that represent health-related research funding agencies and those that inform and set health-related-research funding policy from around the world have come together since 2016 to share, learn, collaborate and influence emerging practice. This group meets under the name of the Ensuring Value in Research Funders' Forum (EViR Funders' Forum). The EViR Funders' Forum worked together to develop a set of ten Guiding Principles, that if funders adhered to would reduce research waste and ensure value in research. Results: The EViR Funders' Forum has previously agreed and published a Consensus Statement. The Forum has agreed on a set of ten Guiding Principles to help health-research funders to maximise the value of research by ensuring that: research priorities are justifiable; the design, conduct and analysis of research minimise bias; regulation and management are proportionate to risks; methods and findings are accessible in full; and findings are appropriately and effectively disseminated and used. Conclusions: When setting research funding policy, we must balance multiple stakeholders' needs and expectations. When funders do this well, they maximise the probability of benefits to society from the research they support - when funders do this badly, they passively allow or actively contribute to research waste. These challenges must be resolved by funders either working together or in conjunction with other actors in the research ecosystem.
Collapse
|
33
|
End the glaring inequity in international science collaborations. Nature 2023; 624:473. [PMID: 38123808 DOI: 10.1038/d41586-023-04022-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2023]
|
34
|
Reardon S. South Korean scientists' outcry over planned R&D budget cuts. Nature 2023; 622:224-225. [PMID: 37798451 DOI: 10.1038/d41586-023-02841-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/07/2023]
|
35
|
A win for science: UK finally joining Horizon Europe will boost research. Nature 2023; 621:229. [PMID: 37700046 DOI: 10.1038/d41586-023-02846-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/14/2023]
|
36
|
Sanderson K, Naddaf M. Scientists celebrate as UK rejoins Horizon Europe research programme. Nature 2023; 621:235-236. [PMID: 37679487 DOI: 10.1038/d41586-023-02812-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/09/2023]
|
37
|
Karimi F, Clauset A. Abolish ageism in early-career research awards. Nature 2023; 620:492. [PMID: 37582878 DOI: 10.1038/d41586-023-02567-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/17/2023]
|
38
|
Conroy G. Can India's new billion-dollar funding agency boost research? Nature 2023; 619:681-682. [PMID: 37464001 DOI: 10.1038/d41586-023-02336-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/20/2023]
|
39
|
Graham SM, Render L, Maqungo S, Ferreira N, Marais LC, Held M, Laubscher M. Establishing a consensus on research priorities in orthopaedic trauma within South Africa. EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY & TRAUMATOLOGY : ORTHOPEDIE TRAUMATOLOGIE 2023; 33:533-540. [PMID: 36752822 DOI: 10.1007/s00590-022-03413-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/23/2022] [Accepted: 10/09/2022] [Indexed: 06/18/2023]
Abstract
BACKGROUND Musculoskeletal (MSK) injuries are one of the leading causes of disability worldwide. Despite improvements in trauma-related morbidity and mortality in high-income countries over recent years, outcomes following MSK injuries in low- and middle-income countries, such as South Africa (SA), have not. Despite governmental recognition that this is required, funding and research into this significant health burden are limited within SA. This study aims to identify research priorities within MSK trauma care using a consensus-based approach amongst MSK healthcare practitioners within SA. METHOD Members from the Orthopaedic Research Collaboration in Africa (ORCA), based in SA, collaborated using a two round modified Delphi technique to form a consensus on research priorities within orthopaedic trauma care. Members involved in the process were orthopaedic healthcare practitioners within SA. RESULTS Participants from the ORCA network, working within SA, scored research priorities across two Delphi rounds from low to high priority. We have published the overall top 10 research priorities for this Delphi process. Questions were focused on two broad groups-clinical effectiveness in trauma care and general trauma public health care. Both groups were represented by the top two priorities, with the highest ranked question regarding the overall impact of trauma in SA and the second regarding the clinical treatment of open fractures. CONCLUSION This study has defined research priorities within orthopaedic trauma in South Africa. Our vision is that by establishing consensus on these research priorities, policy and research funding will be directed into these areas. This should ultimately improve musculoskeletal trauma care across South Africa and its significant health and socioeconomic impacts.
Collapse
|
40
|
Chowdhary S, Defenu N, Musciotto F, Battiston F. Funding bias: nurture European researchers' independence. Nature 2023; 616:33. [PMID: 36977750 DOI: 10.1038/d41586-023-00892-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/30/2023]
|
41
|
Drosatos K, Ktistakis N. Greek scientists desperate for a national research foundation. Nature 2022; 607:657. [PMID: 35882987 DOI: 10.1038/d41586-022-01997-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
42
|
Fernando K, Menon S, Jansen K, Naik P, Nucci G, Roberts J, Wu SS, Dolsten M. Achieving end-to-end success in the clinic: Pfizer's learnings on R&D productivity. Drug Discov Today 2022; 27:697-704. [PMID: 34922020 PMCID: PMC8719639 DOI: 10.1016/j.drudis.2021.12.010] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Revised: 11/19/2021] [Accepted: 12/13/2021] [Indexed: 12/18/2022]
Abstract
Over the past decade, Pfizer has focused efforts to improve its research and development (R&D) productivity. By the end of 2020, Pfizer had achieved an industry-leading clinical success rate of 21%, a tenfold increase from 2% in 2010 and well above the industry benchmark of ∼11%. The company had also maintained the quality of innovation, because 75% of its approvals between 2016 and 2020 had at least one expedited regulatory designation (e.g., Breakthrough Therapy). Pfizer's Signs of Clinical Activity (SOCA) paradigm enabled better decision-making and, along with other drivers (biology and modality), contributed to this productivity improvement. These laid a strong foundation for the rapid and effective development of the Coronavirus 2019 (COVID-19) vaccine with BioNTech, as well as the antiviral candidate Paxlovid™, under the company's 'lightspeed' paradigm.
Collapse
|
43
|
Huang Z, Lan Y, Zha X. Research on government subsidy strategies for new drug R&D considering spillover effects. PLoS One 2022; 17:e0262655. [PMID: 35143496 PMCID: PMC8830673 DOI: 10.1371/journal.pone.0262655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2021] [Accepted: 01/03/2022] [Indexed: 11/18/2022] Open
Abstract
This paper studies the pharmaceutical production supply chain system composed of upstream and downstream pharmaceutical enterprises, and explores the impact of government subsidy strategies on the new drug research and development (R&D) decision variables and profits of pharmaceutical enterprises as well as social welfare, when considering both the horizontal spillover effects within the industry and the vertical spillover effects between industries. Comparing and analyzing the impact of these strategies including non-government subsidy strategy, pharmaceutical enterprise innovation input subsidy strategy, pharmaceutical enterprise innovative product subsidy strategy, patient price subsidy strategy, and patient medical insurance subsidy strategy. By establishing a four-stage Cournot duopoly model incorporating spillover effects, the equilibrium solutions are obtained by backward induction, and the impact of spillover effects on decision variables is investigated accordingly. Studies have shown that: (a) Government subsidy strategies can promote pharmaceutical enterprises’ R&D investment and have a positive incentive effect on the pharmaceutical enterprises’ profits and social welfare. (b) The patient medical insurance subsidy strategy is the optimal subsidy strategy, which can generate higher profits for pharmaceutical enterprises and higher social welfare. (c) The horizontal and vertical spillover effects have different effect on decision variables, enterprises’ profits and social welfare under various subsidy strategies.
Collapse
|
44
|
Zvolanek KM, Goyal V, Hruby A, Ingo C, Sukal-Moulton T. Motivators and barriers to research participation for individuals with cerebral palsy and their families. PLoS One 2022; 17:e0262153. [PMID: 35081120 PMCID: PMC8791530 DOI: 10.1371/journal.pone.0262153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2021] [Accepted: 12/17/2021] [Indexed: 11/18/2022] Open
Abstract
Objective(s) Our objective was to investigate the motivators and barriers associated with the individual or family decision to participate in cerebral palsy research. Based on this information, we offer suggestions to increase the likelihood of participation in future CP studies. Methods A digital survey was administered to stakeholders affected by cerebral palsy across the US. Our analysis focused on variables related to personal interests, travel, and study-specific elements. Statistical tests investigated the effects of responder type, cerebral palsy type, and Gross Motor Function Classification System level on travel and study-specific element variables. Recommendations were informed by responses reflecting the majority of respondents. Results Based on 233 responses, we found that respondents highly valued research participation (on average 88.2/100) and compensation (on average 62.3/100). Motivators included the potential for direct benefit (62.2%) and helping others (53.4%). The primary barriers to participation were schedule limitations (48.9%) and travel logistics (32.6%). Schedule limitations were especially pertinent to caregivers, while individuals with more severe cerebral palsy diagnoses reported the necessity of additional items to comfortably travel. Conclusions Overall, we encourage the involvement of stakeholders affected by cerebral palsy in the research process. Researchers should consider offering flexible study times, accommodating locations, and compensation for time and travel expenses. We recommend a minimum compensation of $15/hour and a maximum time commitment of 4 hours/day to respect participants’ time and increase likelihood of research participation. Future studies should track how attitudes toward research change with time and experience.
Collapse
|
45
|
Zhang K, Liu X, Hong M. Discretionary Effort on Green Technology Innovation: How Chinese Enterprises Act when Facing Financing Constraints. PLoS One 2021; 16:e0261589. [PMID: 34936690 PMCID: PMC8694420 DOI: 10.1371/journal.pone.0261589] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2021] [Accepted: 12/04/2021] [Indexed: 11/19/2022] Open
Abstract
Firm's effort on Green technology innovation (hereafter, called G-innovation) is affected by financing constraints, and firm will make a discretionary choice according to its own situation, to achieve the maximization of self-interests. Based on the data of Chinese micro enterprises, firstly, we empirically analyze firms' decision-making towards G-innovation when faced with financing constraints. It supports the view that financing constraints can hinder enterprise technological innovation. And we also make an explanation that the social benefits of green technology innovation are greater than personal benefits, which makes enterprises tend to reduce green technology innovation when facing financing constraints. Then we examine firms' heterogonous behaviors under different internal attributes and external environments. The results reveal that: First, firms are reluctant to pay more efforts to G-innovation when faced with increased financing constraints. Second, firms with different attributes exhibit heterogeneous G-innovation. Political connections will change firms' willingness to innovate, while the structure of property rights and the pollution degree will not. Third, firms under different external environment also exhibit heterogeneous G-innovation. When economic policy uncertainty increases, firms' willingness to innovate weakens. The development of shadow banks fail to improve firm's willingness to innovate.
Collapse
|
46
|
Chignell SM, Myers ME, Howkins A, Fountain AG. Research sites get closer to field camps over time: Informing environmental management through a geospatial analysis of science in the McMurdo Dry Valleys, Antarctica. PLoS One 2021; 16:e0257950. [PMID: 34735463 PMCID: PMC8568199 DOI: 10.1371/journal.pone.0257950] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2021] [Accepted: 09/13/2021] [Indexed: 11/18/2022] Open
Abstract
As in many parts of the world, the management of environmental science research in Antarctica relies on cost-benefit analysis of negative environmental impact versus positive scientific gain. Several studies have examined the environmental impact of Antarctic field camps, but very little work looks at how the placement of these camps influences scientific research. In this study, we integrate bibliometrics, geospatial analysis, and historical research to understand the relationship between field camp placement and scientific production in the McMurdo Dry Valleys of East Antarctica. Our analysis of the scientific corpus from 1907-2016 shows that, on average, research sites have become less dispersed and closer to field camps over time. Scientific output does not necessarily correspond to the number of field camps, and constructing a field camp does not always lead to a subsequent increase in research in the local area. Our results underscore the need to consider the complex historical and spatial relationships between field camps and research sites in environmental management decision-making in Antarctica and other protected areas.
Collapse
|
47
|
Shao Y, Huang D, Lv L, Yu J. The influence of non-family members in top management teams on research and development investment: Evidence from Chinese family firms. PLoS One 2021; 16:e0258200. [PMID: 34624035 PMCID: PMC8500433 DOI: 10.1371/journal.pone.0258200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2021] [Accepted: 09/21/2021] [Indexed: 11/28/2022] Open
Abstract
The diversified management ability of the non-family members in the top management teams (TMTs) can significantly increase the research and development (R&D) investment of the family firms. However, existing studies focus on family characteristics. To bridge the gap, this study explored the R&D investment propensity for family firms from the perspective of non-family members’ participation in TMTs. Based on the upper echelons and the socioemotional wealth theory, this paper incorporated the non-economic goals that influence strategic decisions on family firms into the analytical framework. According to the questionnaire data of Chinese private enterprises, the Tobit regression model was used to analyze the influence of family members on R&D investment decisions under non-economic goal orientations. The results indicated that the preference for control and influence among family members weakens the positive effect of non-family managers on R&D investment, while the preferences for status perception and social responsibility strengthen the positive effect.
Collapse
|
48
|
Puehringer S, Rath J, Griesebner T. The political economy of academic publishing: On the commodification of a public good. PLoS One 2021; 16:e0253226. [PMID: 34138913 PMCID: PMC8211248 DOI: 10.1371/journal.pone.0253226] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Accepted: 05/06/2021] [Indexed: 11/26/2022] Open
Abstract
This paper provides an institutional and empirical analysis of the highly concentrated market of academic publishing, characterized by over proportionally high profit margins for publishing companies. The availability of latest research findings is an important issue for researchers, universities and politicians alike. Open access (OA) publication provides a promising but also costly solution to overcome this problem. However, in this paper we argue that OA publication costs are an important, but by far not the only way for academic publishers to gain access to public funding. In contrast, our study provides a comprehensive overview of the channels through which public expenditure benefits big academic publishing companies. Furthermore, we offer the results of an explorative case study, where we estimate the annual financial flows of public expenditures in Austria for the field of social sciences. In all, these expenditures add up to about 66.55 to 103.2 million € a year, which amounts to a fourth of total public funding for this field. Against this background, we contribute to the debate whether and to what extent public subsidies are justified for economically successful companies.
Collapse
|
49
|
|
50
|
García-Rio F, Alonso-Arroyo A, de-Granda-Orive JI, Castelló-Cogollos L, Aleixandre-Benavent R. Worldwide production on sleep apnea from 2009-2018. Analysis of the ability to secure funding and international collaboration networks. Respir Med 2021; 185:106486. [PMID: 34089971 DOI: 10.1016/j.rmed.2021.106486] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/16/2021] [Revised: 05/21/2021] [Accepted: 05/23/2021] [Indexed: 12/12/2022]
Abstract
BACKGROUND Obstructive sleep apnea (OSA) is an emerging health problem, but information on scientific production in this subject area is scarce. We aim to evaluate the scientific production on OSA from 2009 to 2018 to illustrate its worldwide distribution, topic areas, and ability to secure funding, as well as to describe international collaboration networks in this field. METHODS Articles published between 2009 and 2018 were extracted from the Science Citation Index Expanded via Web of Science (WoS) using the search term "obstructive sleep apn*". Publication year, number and country of authors, journal, subject category, key words, funding source and number of citations received were recorded. We also conducted network analyses for key words and international collaboration. RESULTS 12,666 articles on OSA were located, which had increased from 895 documents in 2009 to 1592 in 2018. The progressive growth in scientific production on OSA had outpaced the growth rate of total WoS production since 2012.50% of the articles declared some type of funding, with a citation index higher than manuscripts that were not funded. The manuscripts were distributed in journals from 135 subject categories of the WoS, and keyword distribution showed a dispersed pattern with a high number of nodes. The international collaboration rate was 18.2%, and the country network showed the United States as the hegemonic node. CONCLUSION World production on OSA has grown at a higher rate than global production and shows notable thematic dispersion as well as a high ability to secure funding, which increases its impact.
Collapse
|